Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Parmentier

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
Kidney International|February 25, 2011
The possible role of ChemR23/Chemerin axis in the recruitment of dendritic cells in lupus nephritisGiuseppe De Palma, Giuseppe Castellano, Annalisa Del Prete, et al.
Nature Neuroscience|November 22, 2005
The prolactin-releasing peptide antagonizes the opioid system through its receptor GPR10Patrick Laurent, Jerome A J Becker, Olga Valverde, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid dendritic cells, tissue-specific macrophage subpopulations, and eosinophilsThalie Devosse, Aude Guillabert, Nicky D'Haene, et al.
Mabs|May 6, 2017
Antibodies targeting G protein-coupled receptors: Recent advances and therapeutic challengesMohammed Akli Ayoub, Pascale Crépieux, Markus Koglin, et al.
Biochemical Pharmacology|May 15, 2002
Analysis of C-terminally substituted tachykinin-like peptide agonists by means of aequorin-based luminescent assays for human and insect neurokinin receptorsHerbert Torfs, Michel Detheux, Hendrica B Oonk, et al.
Cancers|October 13, 2021
Expression of CCRL2 Inhibits Tumor Growth by Concentrating Chemerin and Inhibiting NeoangiogenesisDiana Al Delbany, Virginie Robert, Ingrid Dubois-Vedrenne, et al.
Pharmacological Reviews|March 3, 2007
International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimersJean-Philippe Pin, Richard Neubig, Michel Bouvier, et al.
Arthritis Research & Therapy|July 19, 2006
Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathiesPaul Proost, Sofie Struyf, Tamara Loos, et al.
Molecular Pharmacology|March 12, 2005
Mutation of the DRY motif reveals different structural requirements for the CC chemokine receptor 5-mediated signaling and receptor endocytosisBernard Lagane, Sébastien Ballet, Thierry Planchenault, et al.
Journal of Virology|January 29, 2003
G protein-dependent CCR5 signaling is not required for efficient infection of primary T lymphocytes and macrophages by R5 human immunodeficiency virus type 1 isolatesAli Amara, Aurore Vidy, Genevieve Boulla, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Kidney International|February 25, 2011
The possible role of ChemR23/Chemerin axis in the recruitment of dendritic cells in lupus nephritisGiuseppe De Palma, Giuseppe Castellano, Annalisa Del Prete, et al.
Nature Neuroscience|November 22, 2005
The prolactin-releasing peptide antagonizes the opioid system through its receptor GPR10Patrick Laurent, Jerome A J Becker, Olga Valverde, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid dendritic cells, tissue-specific macrophage subpopulations, and eosinophilsThalie Devosse, Aude Guillabert, Nicky D'Haene, et al.
Mabs|May 6, 2017
Antibodies targeting G protein-coupled receptors: Recent advances and therapeutic challengesMohammed Akli Ayoub, Pascale Crépieux, Markus Koglin, et al.
Biochemical Pharmacology|May 15, 2002
Analysis of C-terminally substituted tachykinin-like peptide agonists by means of aequorin-based luminescent assays for human and insect neurokinin receptorsHerbert Torfs, Michel Detheux, Hendrica B Oonk, et al.
Cancers|October 13, 2021
Expression of CCRL2 Inhibits Tumor Growth by Concentrating Chemerin and Inhibiting NeoangiogenesisDiana Al Delbany, Virginie Robert, Ingrid Dubois-Vedrenne, et al.
Pharmacological Reviews|March 3, 2007
International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimersJean-Philippe Pin, Richard Neubig, Michel Bouvier, et al.
Arthritis Research & Therapy|July 19, 2006
Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathiesPaul Proost, Sofie Struyf, Tamara Loos, et al.
Molecular Pharmacology|March 12, 2005
Mutation of the DRY motif reveals different structural requirements for the CC chemokine receptor 5-mediated signaling and receptor endocytosisBernard Lagane, Sébastien Ballet, Thierry Planchenault, et al.
Journal of Virology|January 29, 2003
G protein-dependent CCR5 signaling is not required for efficient infection of primary T lymphocytes and macrophages by R5 human immunodeficiency virus type 1 isolatesAli Amara, Aurore Vidy, Genevieve Boulla, et al.
Pageof 12